Showing results (121-130 of 602) with videos related to
Sort By:
Pageof 61
European Journal of Human Genetics : EJHG|September 12, 2013
Variants at IRX4 as prostate cancer expression quantitative trait lociXing Xu, Wasay M Hussain, Joseph Vijai, et al.Leukemia & Lymphoma|April 15, 2003
BRCA1 and BRCA2 germline mutations in lymphoma patientsOrit Yossepowitch, Narciso Olvera, Jaya M Satagopan, et al.JCO Precision Oncology|April 16, 2026
Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary CarcinomaMaksym Misyura, Pier Selenica, Kerem Ozcan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members, Patricia A Ganz, Lorna Kwan, et al.Metabolism: Clinical and Experimental|March 15, 2011
Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer riskVirginia Kaklamani, Nengjun Yi, Kui Zhang, et al.Human Pathology|August 20, 2018
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGAJaclyn F Hechtman, Ghassan K Abou-Alfa, Zsofia K Stadler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel AdenocarcinomaAlicia Latham, Jinru Shia, Zalak Patel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.JAMA Network Open|July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric CancerGeoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal CancerKaryn A Goodman, Diana Julie, Andrea Cercek, et al.Pageof 61